NCT06760052

Longitudinal Data Registry of Plasma Cell Dyscrasia

Longitudinal Data Registry of a Spectrum of Plasma Cell Dyscrasia with Long-term Follow-up

• Status: Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 2,000 (estimated)
• Sponsor: Shanghai Zhongshan Hospital · Academic / Other
• Sex: All
• Age: 19 Years – 99 Years
• Healthy volunteers: Not accepted

Summary

This study aims to identify clinical characteristics, response and clinical outcome of plasma cell dyscrasia (PCD) diagnosed in Zhongshan Hospital, Fudan University from May 2023. In its current version, the registry incorporates historical data (collected from 2007) and is prospectively collecting follow-up data and recording patient outcomes.

Detailed description

PCD is a spectrum of diseases that is being gradually understood in Asia. This study aims to observe and describe the clinical and genetic characteristics of Chinese PCD patients, and to explore the relationship between the characteristics and pathogenesis. It also aims to discover the potential distinct clonal evolution patterns among different subtype of this disease spectrum. This study is a non-interventional real-world, study. Alll registered data are collected from real clinical practice cases. The medical data includes patient demographic, tumor characteristics, laboratory examination, history of treatments, adverse reactions, efficacy results and possible prognostic factors.

Conditions

• Multiple Myeloma and Other Plasma Cell Neoplasms

Timeline

• Start date: 2023-03-01
• Primary completion: 2027-12-31
• Completion: 2028-12-31
• First posted: 2025-01-06
• Last updated: 2025-01-06

Locations

1 site across 1 country: China